Zevenbergen Capital Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-86,015
Closed -$10.7M 109
2025
Q2
$10.7M Sell
86,015
-1,572
-2% -$200K 0.21% 56
2025
Q1
$11.1M Sell
87,587
-25,160
-22% -$3.87M 0.27% 51
2024
Q4
$16.2M Sell
112,747
-16,223
-13% -$2.33M 0.33% 48
2024
Q3
$19.2M Buy
128,970
+323
+0.3% +$46.3K 0.4% 44
2024
Q2
$16.2M Sell
128,647
-1,960
-2% -$307K 0.35% 47
2024
Q1
$24M Buy
130,607
+84
+0.1% +$16K 0.51% 38
2023
Q4
$23.5M Buy
130,523
+1,360
+1% +$212K 0.54% 37
2023
Q3
$20.5M Buy
129,163
+19,040
+17% +$3.11M 0.52% 40
2023
Q2
$15.6M Buy
110,123
+2,877
+3% +$461K 0.37% 47
2023
Q1
$18.1M Buy
107,246
+1,421
+1% +$254K 0.48% 46
2022
Q4
$17.9M Sell
105,825
-2,410
-2% -$437K 0.6% 40
2022
Q3
$20.3M Buy
+108,235
New +$22.8M 0.57% 40

Other funds holding RGEN

Zevenbergen Capital Investments's RGEN Position: Q3 2025 in Review

Zevenbergen Capital Investments sold out of Repligen (RGEN) in Q3 2025, closing a stake of 86,015 shares — an estimated $10.7M sold.

Zevenbergen Capital Investments first reported a position in RGEN in Q3 2022 and held it in 12 quarters. The position peaked at $24M in Q1 2024. 452 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Zevenbergen Capital Investments reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 86,015 Repligen shares in Q3 2025, an estimated $10.7M.
  • Zevenbergen Capital Investments first reported a position in Repligen in Q3 2022 and held it in 12 quarters.
  • Zevenbergen Capital Investments's Repligen position peaked at $24M in Q1 2024.
  • 452 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2025, filed 9 Oct 2025.